
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $110.7M | -- | -- | $0.91 | -- |
08/01/2025 | Q2 | $105.8M | -- | -- | $0.82 | -- |
05/07/2025 | Q1 | $95.8M | $106.4M | $0.79 | $0.78 | $0.01 |
03/06/2025 | Q4 | $95.1M | $49.5M | $0.13 | $0.91 | -$0.78 |
11/07/2024 | Q3 | $100.7M | $105.6M | $0.68 | $0.78 | -$0.10 |
08/01/2024 | Q2 | $96.1M | $108.5M | $0.68 | $0.75 | -$0.07 |
05/02/2024 | Q1 | $90.7M | $97.1M | $0.63 | $0.67 | -$0.04 |
02/28/2024 | Q4 | $90.1M | $97.1M | $0.53 | $0.68 | -$0.15 |
11/08/2023 | Q3 | -- | -- | $0.58 | $0.61 | -$0.03 |
08/02/2023 | Q2 | -- | -- | $0.53 | $0.58 | -$0.05 |
05/03/2023 | Q1 | -- | -- | $0.41 | $0.49 | -$0.08 |
02/24/2023 | Q4 | -- | -- | -$0.93 | $0.58 | -$1.51 |
10/26/2022 | Q3 | -- | -- | $0.60 | $0.61 | -$0.01 |
07/27/2022 | Q2 | -- | -- | $0.30 | $0.74 | -$0.44 |
04/27/2022 | Q1 | -- | -- | $0.55 | $0.53 | $0.03 |
02/22/2022 | Q4 | -- | -- | $0.57 | $0.42 | $0.15 |
10/26/2021 | Q3 | -- | -- | $0.65 | $0.70 | -$0.05 |
07/27/2021 | Q2 | -- | -- | $0.73 | $0.65 | $0.08 |
04/27/2021 | Q1 | -- | -- | $0.57 | $0.64 | -$0.07 |
02/10/2021 | Q4 | -- | -- | $0.65 | $0.68 | -$0.03 |
10/27/2020 | Q3 | -- | -- | $0.40 | $0.58 | -$0.18 |
07/28/2020 | Q2 | -- | -- | $0.47 | $0.45 | $0.02 |
04/28/2020 | Q1 | -- | -- | $0.16 | $0.38 | -$0.22 |
02/26/2020 | Q4 | -- | -- | -$0.62 | $0.46 | -$1.08 |
11/01/2019 | Q3 | -- | -- | $0.31 | $0.46 | -$0.15 |
07/31/2019 | Q2 | -- | -- | $0.66 | $0.53 | $0.13 |
05/01/2019 | Q1 | -- | -- | $0.33 | $0.38 | -$0.05 |
03/05/2019 | Q4 | -- | -- | $0.25 | -- | -- |
11/07/2018 | Q3 | -- | -- | $0.40 | -- | -- |
08/08/2018 | Q2 | -- | -- | $0.47 | -- | -- |
05/09/2018 | Q1 | -- | -- | $0.15 | -- | -- |
03/08/2018 | Q4 | -- | -- | $0.18 | -- | -- |
11/09/2017 | Q3 | -- | -- | $0.38 | -- | -- |
08/10/2017 | Q2 | -- | -- | $0.38 | -- | -- |
05/11/2017 | Q1 | -- | -- | $0.10 | -- | -- |
03/13/2017 | Q4 | -- | -- | $0.87 | -- | -- |
11/10/2016 | Q3 | -- | -- | $0.34 | -- | -- |
08/11/2016 | Q2 | -- | -- | $0.05 | -- | -- |
06/15/2016 | Q1 | -- | -- | $0.13 | -- | -- |
12/31/2015 | Q4 | -- | -- | $0.14 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.29 | -- | -- |
Turning Point Brands reported $106.4M worth of top line sales in its most recent quarter.
Turning Point Brands announced earnings per share of $0.79 which represents a beat of analyst forecast a $0.78 per share.
Turning Point Brands reported $59.6M that represents $3.27 per share over the last quarter.
Turning Point Brands's earnings are forecast to grow from $2.14 per share to $3.43 per share next year representing an increase of 64.49%.
Turning Point Brands's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.